Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
about
Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).MRI-Based Assessment of Safe Margins in Tumor Surgery.Evaluation of the effect of formalin fixation on skin specimens in dogs and catsA prospective evaluation of the impact of second-opinion histopathology on diagnostic testing, cost and treatment in dogs and cats with cancer.Comparison of histologic margin status in low-grade cutaneous and subcutaneous canine mast cell tumours examined by radial and tangential sections.Shaved margin histopathology and imprint cytology for assessment of excision in canine mast cell tumors and soft tissue sarcomas.Surgical margins in the veterinary cancer patient.Soft tissue sarcoma in the dog - Part 2: surgical margins, controversies and a comparative review.Soft tissue sarcoma in the dog - part 1: a current review.HYPOFRACTIONATED RADIOTHERAPY FOR MACROSCOPIC CANINE SOFT TISSUE SARCOMA: A RETROSPECTIVE STUDY OF 50 CASES TREATED WITH A 5 × 6 GY PROTOCOL WITH OR WITHOUT METRONOMIC CHEMOTHERAPY.A Novel Imaging System Distinguishes Neoplastic from Normal Tissue During Resection of Soft Tissue Sarcomas and Mast Cell Tumors in Dogs.Evaluation of histological grade and histologically tumour-free margins as predictors of local recurrence in completely excised canine mast cell tumours.Reductions in margin length after excision of grade II mast cell tumors and grade I and II soft tissue sarcomas in dogs.Curative-intent radical en bloc resection using a minimum of a 3 cm margin in feline injection-site sarcomas: a retrospective analysis of 131 cases.Quantification of surgical margin length changes after excision of feline injection site sarcomas-A pilot study.Oncolytic Sendai Virus Therapy of Canine Mast Cell Tumors (A Pilot Study).
P2860
Q37234363-72533150-4821-4FDB-8BB5-94DE80952CA8Q37632060-32F4C561-43A0-491E-8BD7-D173321D44CBQ37652204-08526088-F879-40E4-AA1C-0FF593A0094FQ38082814-6A637892-EC24-43FE-B61F-2D453657BF3BQ38678959-34DA4837-2FE4-40F1-B353-12DE83482A88Q38688944-F7C045FC-18F7-4361-96EC-93BBEB16BBF7Q38757865-4C783847-4B80-4D85-94ED-818905364EBAQ38761697-4229FECB-C7F3-4800-8EA8-DFF337D0B186Q38953742-2E8D0CED-0E54-4440-961E-2B5E3A835603Q41138441-7A37A742-BEF2-4662-A42B-EEB937FC0A6AQ42054891-E5DAF72D-815E-499B-B058-619C00CF8B0DQ45773136-4EC8F9EC-205C-48DA-9411-CF3D65BFA3CDQ47730467-7379E7D2-2ED8-410E-B25D-07FED89C2E6EQ50536205-85B26DEB-8008-49C8-8B82-2ECD6AAFE4D2Q51003199-CFE73463-2989-48FF-8180-FEF9E07380B3Q55366271-ABC9D77B-B4C5-4459-873E-1705E37310FE
P2860
Use of histologic margin evaluation to predict recurrence of cutaneous malignant tumors in dogs and cats after surgical excision.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Use of histologic margin evalu ...... cats after surgical excision.
@en
Use of histologic margin evalu ...... cats after surgical excision.
@nl
type
label
Use of histologic margin evalu ...... cats after surgical excision.
@en
Use of histologic margin evalu ...... cats after surgical excision.
@nl
prefLabel
Use of histologic margin evalu ...... cats after surgical excision.
@en
Use of histologic margin evalu ...... cats after surgical excision.
@nl
P2093
P1476
Use of histologic margin evalu ...... cats after surgical excision.
@en
P2093
Filippo Scarpa
Laura Marconato
Maria Morini
Ombretta Capitani
P304
P356
10.2460/JAVMA.240.10.1181
P407
P577
2012-05-01T00:00:00Z